<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>MonTa Biosciences Latest Press Releases</title>
<link>https://pressroom.prlog.org/MontaBiosciences/</link>
<description>About MonTa Biosciences - MonTa Biosciences is a Clinical Stage Biotech Company with a vision to develop better cancer treatment to patients by utilizing the immune system to recognize and kill tumor cells</description>
<item><title>MonTa Biosciences Initiates Expansion Phase with TLR7 Agonist MBS8 in Resistant Melanoma</title>
<link>https://www.prlog.org/13129782-monta-biosciences-initiates-expansion-phase-with-tlr7-agonist-mbs8-in-resistant-melanoma.html</link>
<description>MonTa Biosciences, a Copenhagen-based clinical-stage biotech company developing next-generation innate immune modulators for cancer therapy, today announced the expansion of its clinical program with MBS8, a second-generation TLR7 agonist</description><pubDate>Thu, 26 Feb 2026 17:00:00 GMT</pubDate></item>
</channel>
</rss>